- €1.19bn
- €1.52bn
- €3.07bn
Brief: Uniphar Reports 8.2% Organic Gross Profit Growth For 2024
AGM Statement
Holding(s) in Company
Notice of AGM & Annual Report
Holding(s) in Company
Holding(s) in Company
Holding(s) in Company
Executive Restricted Share Plan Dealings
Brief: Uniphar Says Launched €35M Share Buyback Programme
UK Stocks-Factors to watch on February 25 (updated)
Brief: Uniphar FY Adjusted Pretax Profit EUR 61.13 Million
2024 Preliminary Results
UK Stocks-Factors to watch on February 25
Berenberg predicts 'another eventful year' for MedTech sector
Brief: Uniphar Sees Double Digit Organic Gross Profit Growth In 2025 For Uniphar Pharma
Full Year Trading Update and Notice of Results
Holding(s) in Company
Director/PDMR Shareholding
Holding(s) in Company